News | Digital Radiography (DR) | July 21, 2016

Agfa Wins Frost & Sullivan Product Leadership Award in Digital Radiography

Company will highlight MUSICA image processing software, DX-D 100 mobile DR unit at AHRA 2016 meeting in Nashville

Agfa HealthCare, Frost & Sullivan, Product Leadership Award, digital radiography, DR, AHRA 2016

July 21, 2016 — Agfa HealthCare announced it has received Frost & Sullivan’s 2016 North American Product Leadership Award for Digital Radiography (DR). The research group said that Agfa's "complete portfolio of digital, fixed, mobile and retrofit DR systems, as well as impressive radiography advancements, have earned a solid reputation for service excellence and product reliability."

A cornerstone of Agfa's DR value proposition for customers is Multi-Scale Image Contrast Amplification (MUSICA). Agfa's radiation dose is potentially up to 60 percent lower than conventional systems when MUSICA processing is used with cesium bromide (CR) and cesium iodide (DR) detectors. MUSICA processing also enhances image quality and improves workflow. The radiation dose reduction claim has been cleared by the U.S. Food and Drug Administration under the 510(k) pre-market process.

The MUSICA software optimizes and quality-controls images automatically, while competitors' products require operators to manually adjust contrast, density, sharpness and other elements to augment image quality.

At AHRA 2016 in Nashville, Tenn., Agfa will spotlight the wireless, mobile DX-D 100 with FreeView telescopic column. In addition to learning about productivity gains supported by MUSICA, AHRA attendees will be able to discuss how to secure funding for DR even with reduced capital budgets. 

"Now in its third generation, MUSICA is the engine that generates the crisp and detailed images produced by all of Agfa HealthCare's radiography equipment," said Frost & Sullivan Consultant Poornima Srinivasan. "The company offers standardized image quality, low-dose imaging, and the best productivity across its imaging enterprise and radiography fleet."

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality, gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.

For its Product Leadership Award, Frost & Sullivan analysts independently evaluated two key factors, Product Family Attributes and Business Impact, using a customized Decision Support Scorecard. This tool allows their researchers to objectively analyze performance, according to the key benchmarking criteria, and to assign ratings on that basis.

For more information: www.agfahealthcare.com

Related Content

This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America

News | Coronavirus (COVID-19) | June 26, 2020
June 26, 2020 — In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association wit
There were several new developments in digital radiography (DR) technology at the 2019 Radiological Society of North America (RSNA) annual meeting. These trends included integration of artificial intelligence (AI) auto detection technologies, more durable glassless detector plates, and technologies to pull more diagnostic data out of X-ray imaging. Some vendors also have redesigned their DR systems to make them more user-friendly and ergonomic. 
Feature | Digital Radiography (DR) | May 26, 2020 | By Dave Fornell
There were several new developments in digital rad...
Advanced imaging data exchange is now live in Colorado due to the partnership of Health Images and the Colorado Regional Health Information Organization

Getty Images

News | Radiology Business | May 18, 2020
May 18, 2020 — 
World’s largest deployment of a radiology-based AI diagnostic solution for COVID-19 using AI-based chest X-ray technology
News | Coronavirus (COVID-19) | May 18, 2020
May 18, 2020 — Behold.ai announced its partnership with Ap...
Chest radiograph of a 23-year-old male with no past medical history who tested positive for COVID-19 via RT-PCR and was subsequently discharged from the emergency department with home care and isolation precautions. Portable CXR shows right and left peripheral lower lung zone hazy opacities; total score=2

Top image: Chest radiograph of a 23-year-old male with no past medical history who tested positive for COVID-19 via RT-PCR and was subsequently discharged from the emergency department with home care and isolation precautions. Portable CXR shows right and left peripheral lower lung zone hazy opacities; total score=2.

Bottom image: Chest radiograph in a 32-year-old overweight (BMI=30) COVID-19 positive male with a history of childhood asthma who was subsequently admitted and intubated in the ICU for 3 days. Portable CXR shows opacities in all three right lung zones and in the left middle and lower lung zones; total score=5. Image courtesy of Mount Sinai Health System

News | Coronavirus (COVID-19) | May 15, 2020
May 15, 2020 — Chest X-rays performed on young and
Zegami, the Oxford University data visualization spin-out, has announced it has written to the health ministers of ten countries asking them to provide X-rays of COVID-19 infected lungs.
News | Coronavirus (COVID-19) | April 27, 2020
April 27, 2020 — Zegami, the Oxford University data visualization s